Medicine and Dentistry
Cylindroma
100%
Salivary Adenoid Cystic Carcinoma
100%
Cell Proliferation
50%
Metastatic Carcinoma
50%
Promoter Region
50%
Transcription Factors
50%
Breast Cancer
50%
Amino Terminal Sequence
50%
Glucocorticoid Receptor
50%
Neoplasm
45%
Gene Expression
30%
Protein Myb
30%
RNA Sequence
25%
Gene Expression Profiling
25%
Alternative RNA Splicing
16%
Gene Fusion
16%
Rare Tumor
16%
Estrogen Receptor
16%
Overlapping Gene
12%
Tumor Progression
11%
Breast Carcinoma
11%
Perineural Invasion
10%
RNA Sequencing
10%
Salivary Gland Neoplasm
10%
Oncogene
10%
Epitope
10%
Proto Oncogene
8%
Cancer
8%
Salivary Gland
8%
RNA Gene
8%
Uvomorulin
5%
Serous Membrane
5%
Peritoneum
5%
Cell Nucleus Receptor
5%
Cancer Model
5%
Cancer Pathobiology
5%
Mesothelial Cell
5%
S Phase
5%
Extracellular Matrix Protein
5%
Integrin
5%
Breast Tumor
5%
Receptor Expression
5%
Bone Metastasis
5%
Cancer Cell
5%
Biochemistry, Genetics and Molecular Biology
Cell Proliferation
50%
Transcription Factors
50%
Gene Expression
50%
RNA Sequence
50%
Glucocorticoid Receptor
50%
Promoter Region
50%
Gene Expression Profiling
50%
N-Terminus
50%
Clonal Evolution
50%
Somatic Mutation
50%
Myeloid
50%
NUP98
50%
Protein Myb
37%
Alternative Splicing
33%
Gene Fusion
33%
Estrogen Receptor
25%
EN1 (Gene)
25%
RNA
16%
Tumor Progression
16%
Proto Oncogene
16%
RNA Gene
16%
Isoform
12%
RNA Sequencing
12%
Oncogene
12%
Fusion Gene
12%
Extracellular Matrix Protein
8%
Cancer Cell
8%
Wild Type
8%
Mouse
8%
Integrin
8%
Serosa
8%
Surface Property
8%
Nuclear Receptor
8%
Cadherin
8%
S Phase
8%
Keyphrases
Salivary Gland Adenoid Cystic Carcinoma
50%
Transcriptional Activity
50%
Adenoid Cystic Carcinoma
50%
Adult Acute Lymphoblastic Leukemia
50%
Clonal Evolution
50%
Somatic mutation
50%
Nup98
50%
Co-mutation
25%
Peak Finding
12%
Treatment Strategy
12%
Acute Myeloid Leukemia
12%
Valuable Insight
12%
Fusion Gene
12%
Potential Therapeutic Strategies
12%
Multiple Centers
12%
Clinical Significance
12%
Pediatric Patients
12%
Disease Progression
12%
Adult Patients
12%
RNA Sequencing (RNA-seq)
10%
Tumor Subtype
10%
Oncogene
10%
Patient Samples
10%
Salivary Gland Tumor
10%
New Therapeutics
10%
Therapeutic Potential
10%
N-terminal Domain
10%
Overexpression
10%
Alternative Promoter
10%
Perineural Invasion
10%
Epitope
10%
Regulatory Pathways
10%
Tumor
10%
MYB Protein
8%
Low-quality RNA
8%
Serosal Membranes
7%
